Video
Implications of Controlling Psoriasis Inflammation: From Molecular Profiling to Comorbidities.
Dr. Alex Tsoi addresses three questions in his presentation—what is controlled inflammation, what limits it, and why…
Dr. Alex Tsoi addresses three questions in his presentation—what is controlled inflammation, what limits it, and why…
Watch VideoIPC summarizes presentations from its symposium at the 2026 SID Annual Meeting, including disease interception,…
View ReportThe 2024 Society for Investigative Dermatology (SID) Annual Meeting was held from May 14 to 18, 2024, in Dallas, Texas,…
Read MoreDr. Alex Tsoi discusses the regulatory roles of psoriasis-associated loci keratinocytes, regulatory network and…
Watch VideoSOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) | DALLAS, TEXAS Wednesday, May 15 9:00 - 12:00 CDT Program chairs:…
Read key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving…
Read MoreDr. Alex Tsoi discusses IBD as a comorbidity of psoriasis and further examines their existing shared genetic regions.
Watch VideoDr. Alex Tsoi assesses psoriasis patient statistics, investigating the causal relationship between comorbidities within…
Watch VideoIPC GLOBAL WEBINAR SERIES Wednesday, December 13 12:30 - 13:30 CET 6:30 - 7:30 EST Program chair: Akimichi Morita,…
Dr. Tsoi discusses his research on the effects Ixekizumab and Guselkumab has on IL-17/IL-23 pathway gene expression in…
Watch VideoIntroducing IPC’s newest Councilors for 2023: A cohort of global experts dedicated to improving patient care for…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.